Design of a liquid nano-sized drug delivery system with enhanced solubility of rivaroxaban for venous thromboembolism management in paediatric patients and emergency cases

References

• Abdallah, M.A., Al-Ghobashy, M.A., and Lotfy, H.M., 2015. Investigation of the profile and kinetics of degradation of rivaroxaban using HPLC, TLC-densitometry and LC/MS/MS: application to pre-formulation studies. Bulletin of faculty of pharmacy, Cairo university, 53 (1), 53–61.
   Google Scholar
• Abdelbary, G., Amin, M., and Salah, S., 2013. Self nano-emulsifying simvastatin based tablets: design and in vitro/in vivo evaluation. Pharmaceutical development and technology, 18 (6), 1294–1304.
   PubMed Web of Science ®Google Scholar
• Agrawal, A.G., Kumar, A., and Gide, P.S., 2015. Formulation of solid self-nanoemulsifying drug delivery systems using N-methyl pyrrolidone as cosolvent. Drug development and industrial pharmacy, 41 (4), 594–604.
   PubMed Web of Science ®Google Scholar
• Balakumar, K., et al., 2013. Self nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation. Colloids and surfaces. B, biointerfaces, 112, 337–343.
   PubMed Web of Science ®Google Scholar
• Beg, S., et al., 2012. Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers. AAPS PharmSciTech, 13 (4), 1416–1427.
   PubMed Web of Science ®Google Scholar
• Begum, R., et al., 2015. Inhibitory effect of Careya arborea on inflammatory biomarkers in carrageenan-induced inflammation. Pharmaceutical biology, 53 (3), 437–445.
   PubMed Web of Science ®Google Scholar
• Cuker, A., et al., 2014. Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants. Journal of the American college of cardiology, 64 (11), 1128–1139.
   PubMed Web of Science ®Google Scholar
• Elnaggar, Y.S., El-Massik, M.A., and Abdallah, O.Y., 2009. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. International journal of pharmaceutics, 380 (1–2), 133–141.
   PubMed Web of Science ®Google Scholar
• European Medicine Agency, 2008. CHMP assessment report for Xarelto.
   Google Scholar
• Fahmy, U.A., Ahmed, O.A., and Hosny, K.M., 2015. Development and evaluation of avanafil self-nanoemulsifying drug delivery system with rapid onset of action and enhanced bioavailability. AAPS PharmSciTech, 16 (1), 53–58.
   PubMed Web of Science ®Google Scholar
• Fluri, F., Heinen, F., and Kleinschnitz, C., 2013. Intravenous thrombolysis in a stroke patient receiving rivaroxaban. Cerebrovascular diseases extra, 3 (1), 153–155.
   PubMedGoogle Scholar
• Harenberg, J., et al., 2011. Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variability. Journal of thrombosis and thrombolysis, 32 (3), 267–271.
   PubMed Web of Science ®Google Scholar
• Heshmati, N., et al., 2013. Enhancement of oral bioavailability of E804 by self-nanoemulsifying drug delivery system (SNEDDS) in rats. Journal of pharmaceutical sciences, 102 (10), 3792–3799.
   PubMed Web of Science ®Google Scholar
• Hosny, K.M. and Banjar, Z.M., 2013. The formulation of a nasal nanoemulsion zaleplon in situ gel for the treatment of insomnia. Expert opinion on drug delivery, 10 (8), 1033–1041.
   PubMed Web of Science ®Google Scholar
• Kang, B.K., et al., 2004. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. International journal of pharmaceutics, 274 (1–2), 65–73.
   PubMed Web of Science ®Google Scholar
• Kassem, A.A., et al., 2016. Self-nanoemulsifying drug delivery system (SNEDDS) with enhanced solubilization of nystatin for treatment of oral candidiasis: design, optimization, in vitro and in vivo evaluation. Journal of molecular liquids, 218, 219–232.
   Web of Science ®Google Scholar
• Khattab, A., Hassanin, L., and Zaki, N., 2017. Self-nanoemulsifying drug delivery system of coenzyme (Q10) with improved dissolution, bioavailability, and protective efficiency on liver fibrosis. AAPS PharmSciTech, 18 (5), 1657–1672.
   PubMed Web of Science ®Google Scholar
• Kommuru, T., et al., 2001. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. International journal of pharmaceutics, 212 (2), 233–246.
   PubMed Web of Science ®Google Scholar
• Kuhle, S., et al., 2004. Systemic thromboembolism in children. Thrombosis and haemostasis, 92, 722–728.
   PubMed Web of Science ®Google Scholar
• Lawrence, M.J. and Rees, G.D., 2012. Microemulsion-based media as novel drug delivery systems. Advanced drug delivery reviews, 64, 175–193.
   Web of Science ®Google Scholar
• Liu, F.D., et al., 2018. Rivaroxaban does not influence hemorrhagic transformation in a diabetes ischemic stroke and endovascular thrombectomy model. Scientific reports, 8, 7408.
   PubMed Web of Science ®Google Scholar
• Mahmoud, D.B., Shukr, M.H., and Bendas, E.R., 2014. In vitro and in vivo evaluation of self-nanoemulsifying drug delivery systems of cilostazol for oral and parenteral administration. International journal of pharmaceutics, 476 (1–2), 60–69.
   PubMed Web of Science ®Google Scholar
• Nayak, A.K. and Panigrahi, P.P., 2012. Solubility enhancement of etoricoxib by cosolvency approach. ISRN physical chemistry, 2012, 1.
   Google Scholar
• Parmar, N., et al., 2011. Study of cosurfactant effect on nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery system. Colloids and surfaces B biointerfaces, 86 (2), 327–338.
   PubMed Web of Science ®Google Scholar
• Perzborn, E., et al., 2011. The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor. Nature reviews drug discovery, 10 (1), 61–75.
   PubMed Web of Science ®Google Scholar
• Pouton, C.W. and Porter, C.J., 2008. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Advanced drug delivery reviews, 60 (6), 625–637.
   PubMed Web of Science ®Google Scholar
• Raffini, L., et al., 2009. Dramatic increase in venous thromboembolism in children’s hospitals in the United States from 2001 to 2007. Pediatrics, 124 (4), 1001–1008.
   PubMed Web of Science ®Google Scholar
• Ram I.M. and Ajit S.N., 2011. Pharmaceutical dosage forms and drug delivery. 2nd ed. Boca Raton, FL: CRC Press.
   Google Scholar
• Shafiq, S., et al., 2007. Development and bioavailability assessment of ramipril nanoemulsion formulation. European journal of pharmaceutics and biopharmaceutics, 66 (2), 227–243.
   PubMed Web of Science ®Google Scholar
• Shaji, J. and Jadhav, D., 2010. Newer approaches to self emulsifying drug delivery system. International journal of pharmacy and pharmaceutical sciences, 2, 37–42.
   Google Scholar
• Shakeel, F., et al., 2014. Polymeric solid self-nanoemulsifying drug delivery system of glibenclamide using coffee husk as a low cost biosorbent. Powder technology, 256, 352–360.
   Web of Science ®Google Scholar
• Singh, A.K., et al., 2009. Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS). AAPS PharmSciTech, 10 (3), 906–916.
   PubMed Web of Science ®Google Scholar
• Söderlind, E., Wollbratt, M., and von Corswant, C., 2003. The usefulness of sugar surfactants as solubilizing agents in parenteral formulations. International journal of pharmaceutics, 252, 61–71.
   PubMed Web of Science ®Google Scholar
• Souri, E., et al., 2016. Development of a stability-indicating HPLC method and a dissolution test for rivaroxaban dosage forms. Acta chromatographica, 28 (3), 347–361.
   Web of Science ®Google Scholar
• Stampfuss, J., et al., 2013. The effect of food on the absorption and pharmacokinetics of rivaroxaban. International journal of clinical pharmacology and therapeutics , 51 (7), 549–561.
   PubMed Web of Science ®Google Scholar
• Tang, S.Y., et al., 2012. Formulation development and optimization of a novel Cremophore EL-based nanoemulsion using ultrasound cavitation. Ultrasonics sonochemistry, 19 (2), 330–345.
   PubMed Web of Science ®Google Scholar
• Wang, F., et al., 2018. Pharmacokinetics, tissue distribution, bioavailability, and excretion of nuciferine, an alkaloid from lotus, in rats by LC/MS/MS. Drug development and industrial pharmacy, 44 (9), 1557–1562.
   PubMed Web of Science ®Google Scholar
• Wang, Z., et al., 2010. Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. International journal of pharmaceutics, 383 (1–2), 1–6.
   PubMed Web of Science ®Google Scholar
• Wertz, R.K. and Koepke, J.A., 1977. A critical analysis of platelet counting methods. American journal of clinical pathology, 68, 195–201.
   PubMed Web of Science ®Google Scholar
• Willmann, S., et al., 2014. Development of a paediatric population-based model of the pharmacokinetics of rivaroxaban. Clinical pharmacokinetics, 53 (1), 89–102.
   PubMed Web of Science ®Google Scholar